Global bipolar disorder market projected to grow to USD 6.47 billion by 2033 with rising prevalence.

From GlobeNewswire: 2024-06-13 21:00:00

The global bipolar disorder market is projected to grow from USD 5.32 billion in 2023 to USD 6.47 billion by 2033, with a CAGR of 1.98%. Factors driving market growth include the rising prevalence of bipolar disorder, developments in drug combinations, increased R&D efforts, and government initiatives in healthcare. The bipolar I disorder segment is expected to hold the largest share. Antipsychotic drugs are projected to see the fastest growth. North America is expected to lead the market, while Asia Pacific is forecasted to have the fastest CAGR.

In recent news, NRx Pharmaceuticals, Inc. announced that NRX-101 showed statistically significant safety improvements over standard care in patients with suicidal bipolar depression. The market segmentation includes types like bipolar I disorder, bipolar II disorder, and drug classes such as mood stabilizers, anticonvulsants, antipsychotic drugs, and antidepressant drugs. Major vendors in the market include Bristol Myers Squibb, Eli Lilly, and GlaxoSmithKline. The report provides insights into recent developments and competitive analysis in the global bipolar disorder market.



Read more at GlobeNewswire: Global Bipolar Disorder Market Size To Exceed USD 6.47